SCHEMBL4362385

SCHEMBL4362385

Cc1nn(C2CCNCC2)c2ncnc(Oc3cc(F)c(F)cc3F)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.40
SRC P12931 10/20 0.39
EIF2AK3 Q9NZJ5 2/20 0.39
PIK3CD O00329 8/20 0.39
ABL1 P00519 8/20 0.39
EGFR P00533 8/20 0.39
HCK P08631 8/20 0.39
KDR P35968 8/20 0.39
PIK3CA P42336 8/20 0.39
PIK3CB P42338 8/20 0.39
MTOR P42345 8/20 0.39
PIK3CG P48736 8/20 0.39
EPHB4 P54760 8/20 0.39
PRKDC P78527 8/20 0.39
PI4KB Q9UBF8 7/20 0.39
NR3C1 P04150 2/20 0.38
LCK P06239 1/20 0.37
HTR1A P08908 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1128311 0.79 GPR119 (0.48) NR3C1CYP2C9
Hydrochloric Acid SCHEMBL1128930 0.78 CYP3A4 (0.41) SRCEIF2AK3ABL1HTR1ASLC6A2
SCHEMBL1128995 0.75 CYP3A4 (0.48) FGFR1SRCEIF2AK3NR3C1LCK
SCHEMBL24196837 0.75 SRC (0.54) FGFR1SRCPIK3CDABL1EGFR
SCHEMBL4359027 0.68 CYP3A4 (0.38) CYP3A4CYP2C9
SCHEMBL24251925 0.68 SRC (0.57) FGFR1SRCPIK3CDABL1EGFR
SCHEMBL31693325 0.66 JAK2 (0.40) FGFR1SRCPIK3CDABL1EGFR
SCHEMBL31693335 0.66 JAK2 (0.40) FGFR1SRCPIK3CDABL1EGFR
SCHEMBL27834954 0.66 NR3C1 (0.45) FGFR1SRCEIF2AK3PIK3CDABL1
SCHEMBL24196618 0.65 BTK (0.63) SRCPIK3CDABL1EGFRHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188098-B2 GPR119 receptor agonists HOFFMANN-LA ROCHE INC. (US) 2012-05-29 US disclosed
US-20090286812-A1 GPR119 Receptor Agonists ERICKSON SHAWN DAVID 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286812-A1 GPR119 Receptor Agonists GPR119, GPR27, GPR139 FGFR1 458/4885SRC 2944/4885EIF2AK3 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.